Avp - arginine vasopressin Gene

Also Known as Vp; Vsp

Species: Mus musculus

Gene Type: protein coding
Gene ID: 11998

Summary

This gene encodes a member of the vasopressin/oxytocin family and preproprotein that is proteolytically processed to generate multiple protein products. These products include the neuropeptide hormone arginine vasopressin, and two Other peptides, neurophysin 2 and copeptin. Arginine vasopressin binds to vasopressin receptors and functions as a vasopressor, to constrict blood vessels and increase blood pressure, and as an antidiuretic, to reduce the production of urine. Neurophysin 2 functions as a carrier protein in the transport of arginine vasopressin. This gene is present in a gene cluster with the related gene oxytocin on chromosome 2. [provided by RefSeq, Aug 2015]

Avp Products (1)

mRNA Protein Name
NM_009732.2 NP_033862.1 vasopressin-neurophysin 2-copeptin preproprotein
Protein Preferred Names Protein Names

vasopressin-neurophysin 2-copeptin

  • AVP-NPII

  • pre-pro-arginine-vasopressin-neurophysin II

  • prepro-AVP-NP II

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (6)
Cat. No. 상품명 효과
Purity Rare Diseases
HY-17000 Tolvaptan 99.95% Yes
HY-B1811 Vasopressin 99.65% Yes
HY-P0049 Argipressin Agonist 98.71% Unkown
HY-18346 Mozavaptan Antagonist 99.71% Unkown
HY-123593 Mozavaptan hydrochloride Antagonist 99.80% Unkown
HY-P0049A Argipressin diacetate / Unkown

Clinical Phase

Bioactive Molecules (4)
Cat. No. 상품명 효과
Purity Phase
HY-W539944 Argipressin acetate 99.16% Phase 4
HY-10066 Nelivaptan Antagonist 99.89% Phase 2
HY-133173 Niravoline Agonist / Phase 2
HY-19070 BRL-52656 Agonist / Phase 1

Pre-clinical Phase

Bioactive Molecules (27)
Cat. No. 상품명
효과
Purity
Rare Diseases
HY-103023 CLP290 Activator 99.96% Unkown
HY-P1390 d[Cha4]-AVP Agonist 98.81% Unkown
HY-RS09357 NLRP3 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-103703 DEAE Cross-linked dextran A 25 / Unkown
HY-134454A Z-Pro-prolinal Inhibitor 99.9% Unkown
HY-157220 Tolvaptan phosphate ester sodium Antagonist 99.85% Unkown
HY-P3066 SKF 100398 99.48% Unkown
HY-P4990 Pro8-Oxytocin Activator 99.68% Unkown
HY-P4990A Pro8-Oxytocin TFA Activator 99.68% Unkown
HY-RS06579 IFNAR1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-118768 FMS586 free base / Unkown
HY-165484 AVP-13358 Inhibitor / Unkown
HY-18346S Mozavaptan-d6 Antagonist / Unkown
HY-P10046 [Deamino-Pen1,Val4,D-Arg8]-vasopressin Inhibitor / Unkown
HY-P1390A d[Cha4]-AVP TFA Agonist / Unkown
HY-P1747 Pneumadin, rat / Unkown
HY-P4010 Desamino(D-3-(3′-pyridyl)-Ala2,Arg8)-Vasopressin Agonist / Unkown
HY-P5007 Copeptin (human) / Unkown
HY-RS01280 AVP Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W583271 Zn(II) Deuteroporphyrin IX 2,4 bis ethylene glycol Inhibitor / Unkown
HY-111291 ICI 169369 free base Inhibitor / Unkown
HY-118918 YM218 free base Antagonist / Unkown
HY-129333 L-364918 Antagonist / Unkown
HY-17000S Tolvaptan-d7 / Unkown
HY-P5006 (d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin Antagonist / Unkown
HY-RS16746 Avp Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23183 Avp Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Avp NCBI NCBI:551